Vergoeding 2015-2019 voor ATC-subgroep L04AX : Overige immunosuppressiva
- Raming voor de totale Zvw-populatie
2015 | 2016 | 2017 | 2018 | 2019 | |
---|---|---|---|---|---|
L04AX01 Azathioprine (Azafalk ®) | 2.167.800 | 2.169.900 | 1.941.100 | 2.031.400 | 2.010.200 |
L04AX02 Thalidomide | 4.348 | . | . | . | . |
L04AX03 Methotrexaat (Injexate ®) | 8.275.900 | 17.206.900 | 21.558.200 | 22.231.500 | 21.867.600 |
L04AX05 Pirfenidon (Esbriet ®) | 6.148.200 | 6.531.900 | 6.873.800 | 8.824.600 | 10.304.300 |
L04AX07 Dimethylfumaraat (Tecfidera ®) | 16.075.200 | 20.508.000 | 23.228.100 | 32.246.400 | 38.396.100 |
Totaal | 32.671.448 | 46.416.700 | 53.601.200 | 65.333.900 | 72.578.200 |